Bactiguard Holding AB (OSTO:BACTI B)
kr 67.8 -1.2 (-1.74%) Market Cap: 2.38 Bil Enterprise Value: 2.52 Bil PE Ratio: 0 PB Ratio: 6.92 GF Score: 73/100

Q1 2022 Bactiguard Holding AB Earnings Call Transcript

Apr 27, 2022 / 09:00AM GMT
Release Date Price: kr116.4 (-1.36%)
Anders GÃ;ransson
Bactiguard Holding AB - CEO

¶ -

Welcome to the call to all our shareholders, investors, analysts, and others who have joined today. We will share our Q1 results as well as a deep dive into our expanding license business, with a focus on the two new agreements we have signed with Zimmer Biomet as well as Dentsply Sirona, leading companies in their fields within orthopedics and the dental area.

Let's go to page 2. In our last quarterly call, we presented a new focused growth strategy as well as new financial goals. Core to our strategy is our vision of keeping people safe from infections. We do so by fighting the infections to save lives, limit antimicrobial resistance, and save cost for the healthcare system by providing safe and effective technology.

We will today share how we are executing on our strategy with a clear focus of getting our technologies to patients.

If we go to page 3 in an overview of our Q1 results. We had a strong sales quarter, both in license revenue through our partnerships with leading global medtech companies, a total of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot